Concepedia

Brenda F. Baker

BF

Statistics

Publications

57

Citations

9.2K

H-Index

42

Active since

1985

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of California San Diego

Amsterdam UMC Location University of Amsterdam

University of Amsterdam

University at Buffalo, State University of New York

Brenda F. Baker is an author at Ionis Pharmaceuticals (United States) specializing in medicine, natural sciences, and molecular biology.

ORCID

Top concepts

Publications per year

1985–2022

57

Publications

57

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Cardiovascular and Metabolic Effects of <i>ANGPTL3</i> Antisense Oligonucleotides

Mark J. Graham, Richard Lee, Teresa Brandt et al. · New England Journal of Medicine · 2017 · 567 citations · Full text

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

Daniel Gaudet, Veronica J. Alexander, Brenda F. Baker et al. · New England Journal of Medicine · 2015 · 515 citations · Full text

Targeting APOC3 in the Familial Chylomicronemia Syndrome

Daniel Gaudet, Diane Brisson, Karine Tremblay et al. · New England Journal of Medicine · 2014 · 477 citations · Full text

, , +18

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

Sotirios Tsimikas, Nicholas J. Viney, Steven G. Hughes et al. · The Lancet · 2015 · 460 citations

, , +7

1–5 of 57